Research on the treatment and prevention of malaria in pregnancy in sub-Saharan Africa: East Africa Regional Meeting

11-12 July 2016 - Fairview Hotel - Nairobi, Kenya

For the full meeting report please click here.  Photos from the event can be viewed here

 

Welcome and Introductions    
Malaria in Pregnancy Consortium Overview & Objectives of the Meeting

Feiko ter Kuile & Jenny Hill

Liverpool School of Tropical Medicine

     
Burden of Malaria in preganancy in the East Africa Region

Patrick Walker

Imperial College London

Data not published
Session 1: Use of ACTs for case management of malaria in all trimesters of pregnancy
     
Safety, efficacy and dosing of ACTs for treatment of clinical malaria in 2nd and 3rd trimesters in Africa

Michael Nambozi

Tropical Diseases Research Centre (TDRC), Zambia

     
Safety of ACTs and quinine in early pregnancy in Africa

Feiko ter Kuile

Liverpool School of Tropical Medicine

Data not published
     
Knowledge and adherence to national guidelines for malaria case management in pregnancy among helathcare providers and drug outlets in western Kenya

Simon Kariuki

Kenya Medical Research Institute (KEMRI)

     
Session 2: IPTp with 2 vs 3 or more doses of SP and the impact of SP resistance
     
Effectiveness and cost effectiveness of 2 vs 3+ doses of IPTp with SP

Feiko ter Kuile

Liverpool School of Tropical Medicine

     
Impact of SP resistance on the effectiveness of IPTp with SP in sub-Saharan Africa

Annemieke van Eijk

Liverpool School of Tropical Medicine

Data not published
     
Effectiveness of antenatal clinics to deliver IPTp-SP in contect of other ANC services

Jenny Hill

Liverpool School of Tropical Medicine

     
Experiences of implementing current MiP policies - national programme perspectives:

Peter Njim and Elizabeth Washika

Kenya Ministry of Health, National Malaria Control Programme

 

Diana Khonje & Shadreck Mulenga

Malawi Ministry of Health, National Malaria Control Programme

 

Baltazar Candrinho

Mozambique Ministry of Health, National Malaria Control Programme

 

Victor Chalwe

Zambia Ministry of Health

 
Session 3: Implications for current policies: Summary and discussion to end day 1
     
Session 4: Alternative drugs for UPTp and alternative screen and treat approaches (ISTp)
     
Lessons learnt from IPTp with Mefloquine clinical trials in Benin, Gabon, Kenya, Mozambique and Tanzania

Raquel Gonzales

IS Global

     
Intermittent screening and treatment (ISTp) compared to IPTp-SP in Kenya and Malawi

Mwayi Madanitsa

College of Medicine, Malawi

     
User and provider acceptability of alternative drugs for IPTp and ISTp under trial conditions in Ghana, Malawi and Kenya

Jayne Webster

London School of Hygiene and Tropical Medicine

Data not published
     
Session 5: Implications for national policies and programmes    
     
Potential challenges for MiP policy change and implementation of new policies - national programme perspectives: MOH Representative Thoughts and Presentations

Peter Njim and Elizabeth Washika

Kenya Ministry of Health, National Malaria Control Programme

 

Diana Khonje & Shadreck Mulenga

Malawi Ministry of Health, National Malaria Control Programme

 

Baltazar Candrinho

Mozambique Ministry of Health, National Malaria Control Programme

 

Georgina Msemo

Tanzania Ministry of Health

 

Victor Chalwe

Zambia Ministry of Health